Faldet i SeSBT/ SeDBT ved 5 uger var henholdsvis 30, 8/ 24, 0 mmHg og 21, 1/ 19, 3 mmHg for irbesartan/ hydrochlorothiazid og irbesartan (p < 0, 0001).
The mean baseline blood pressure was approximately 172/ 113 mmHg in each treatment group and decreases of SeSBP/ SeDBP at five weeks were 30.8/ 24.0 mmHg and 21.1/ 19.3 mmHg for irbesartan/ hydrochlorothiazide and irbesartan, respectively (p < 0.0001).